Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-086908

Vitae Pharmaceuticals, Inc · VTAE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeffrey S. Hatfield
Officer — Chief Executive Officer · Director
Period of report
Dec 23, 2015
Accepted (ET)
Dec 28, 2015 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 23, 2015M5,584$3.45A272,944D
Common StockDec 23, 2015M16,940$3.45A289,884D
Common StockDec 23, 2015S22,524$17.00D267,360D
Common StockDec 28, 2015M26,537$3.45A293,897D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F2$3.45Dec 23, 2015M5,584D—Mar 28, 2016Common Stock5,5840D
Employee Stock Option (Right to Buy)F3$3.45Dec 23, 2015M16,940D—Mar 28, 2016Common Stock16,9400D
Employee Stock Option (Right to Buy)F4$3.45Dec 28, 2015M26,537D—Mar 28, 2016Common Stock26,5370D

Explanation of responses